Mechanical and thermo-mechanical properties of carbon nanotube reinforced composites

A study on the mechanical and thermo-mechanical properties of carbon nanotube (CNT) reinforced nanocomposites is presented in this article. Mori-Tanaka method is used for modeling the effective stiffness and coefficient of thermal expansion. Regression formulas were developed to describe the effects of CNT orientation, aspect ratio, and CNT volume fraction. Given the statistical distributions of CNT orientations and aspect ratios, the effective properties can be conveniently derived by numerical integration using these formulas

Collapse of composite tubes under end moments

Cylindrical tubes of moderate wall thickness such as those proposed for the original space station truss, may fail due to the gradual collapse of the tube cross section as it distorts under load. Sometimes referred to as the Brazier instability, it is a nonlinear phenomenon. This paper presents an extension of an approximate closed form solution of the collapse of isotropic tubes subject to end moments developed by Reissner in 1959 to include specially orthotropic material. The closed form solution was verified by an extensive nonlinear finite element analysis of the collapse of long tubes under applied end moments for radius to thickness ratios and composite layups in the range proposed for recent space station truss framework designs. The finite element analysis validated the assumption of inextensional deformation of the cylindrical cross section and the approximation of the material as specially orthotropic

Theoretical prediction of CNT-CF/PP composite tensile properties using various numerical modeling methods

Development of effective models to predict tensile properties of ‘carbon nanotube coated carbon fibre reinforced polypropylene (CNT-CF/PP)’ composites is briefly discussed. The composite taken as the reference is based on the highest growth mechanism of CNTs over carbon fibres. Halpin-Tsai and Combined Voigt-Reuss model has been implemented. Young's modulus for CNT-CF/PP composites has been found 4.5368 GPa and the tensile strength has been estimated 45.367 MPa considering the optimum operating condition of chemical vapor deposition (CVD) technique. Stiffness of the composite is represented through the stress-strain plots; stiffness is proportional to the steepness of the slope. There are slight deviations of results that have been found theoretically over the experimental issues

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

BACKGROUND: Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving limited insights into mucosal defences that prevent viral replication and onward transmission. We studied nasal and plasma antibody responses one year after hospitalisation for COVID-19, including a period when SARS-CoV-2 vaccination was introduced. METHODS: In this follow up study, plasma and nasosorption samples were prospectively collected from 446 adults hospitalised for COVID-19 between February 2020 and March 2021 via the ISARIC4C and PHOSP-COVID consortia. IgA and IgG responses to NP and S of ancestral SARS-CoV-2, Delta and Omicron (BA.1) variants were measured by electrochemiluminescence and compared with plasma neutralisation data. FINDINGS: Strong and consistent nasal anti-NP and anti-S IgA responses were demonstrated, which remained elevated for nine months (p < 0.0001). Nasal and plasma anti-S IgG remained elevated for at least 12 months (p < 0.0001) with plasma neutralising titres that were raised against all variants compared to controls (p < 0.0001). Of 323 with complete data, 307 were vaccinated between 6 and 12 months; coinciding with rises in nasal and plasma IgA and IgG anti-S titres for all SARS-CoV-2 variants, although the change in nasal IgA was minimal (1.46-fold change after 10 months, p = 0.011) and the median remained below the positive threshold determined by pre-pandemic controls. Samples 12 months after admission showed no association between nasal IgA and plasma IgG anti-S responses (R = 0.05, p = 0.18), indicating that nasal IgA responses are distinct from those in plasma and minimally boosted by vaccination. INTERPRETATION: The decline in nasal IgA responses 9 months after infection and minimal impact of subsequent vaccination may explain the lack of long-lasting nasal defence against reinfection and the limited effects of vaccination on transmission. These findings highlight the need to develop vaccines that enhance nasal immunity. FUNDING: This study has been supported by ISARIC4C and PHOSP-COVID consortia. ISARIC4C is supported by grants from the National Institute for Health and Care Research and the Medical Research Council. Liverpool Experimental Cancer Medicine Centre provided infrastructure support for this research. The PHOSP-COVD study is jointly funded by UK Research and Innovation and National Institute of Health and Care Research. The funders were not involved in the study design, interpretation of data or the writing of this manuscript

Simplified transverse Young's modulus of aligned ribbon-reinforced composites by the mechanics-of-materials approach

Journal of Reinforced Plastics and Composites223257-269JRPC